Jiaqiang Wu

Jiaqiang Wu

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JWJinbao Wang
Jinbao Wang
PZPengwei Zhao
Pengwei Zhao
LGLihui Guo
Lihui Guo
YLYueyue Liu
Yueyue Liu
YDYijun Du
Yijun Du
JWJiaqiang Wu
Jiaqiang Wu

21 December 2021 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
LDLuo-Gang Ding
Luo-Gang Ding
SWSong Wang
Song Wang
BYBing-Jian Yao
Bing-Jian Yao
WWWen-Xiu Wu
Wen-Xiu Wu
JKJing-Lan Kan
Jing-Lan Kan
YDYubin Dong
Yubin Dong
A COF-based multifunctional reusable face mask, which exhibits solar-powered self-sanitizing ability with excellent antibacterial and antiviral performance via a triple-modal synergistic treatment, is reported.

6 February 2023 in Porcine Health Management
Verified
Journal Article
Open access
PDF file
YZYue Zhang
Yue Zhang
YZYuyu Zhang
Yuyu Zhang
FLFei Liu
Fei Liu
YMYanwei Mao
Yanwei Mao
YZYimin Zhang
Yimin Zhang
JLJun Li
Jun Li
Probiotics can improve animal health by regulating intestinal flora balance, improving the structure of the intestinal mucosa, and enhancing intestinal barrier function. At present, the use of probiotics has been a research hotspot in prevention and treatment of different diseases at home and abroad. This review has summarized the researchers and applications of probiotics in prevention and treatment of swine diseases, and elaborated the relevant mechanisms of probiotics, which aims to provide a reference for probiotics better applications to the prevention and treatment of swine diseases.

23 January 2025 in Advanced Functional Materials
Verified
Journal Article
Closed access
LDLuo‐Gang Ding
Luo‐Gang Ding
MSMin Shi
Min Shi
YXYu‐Lin Xu
Yu‐Lin Xu
EYEr‐Di Yu
Er‐Di Yu
YZYu‐Yu Zhang
Yu‐Yu Zhang
JWJiaqiang Wu
Jiaqiang Wu

15 July 2010 in Virology Journal
Verified
Journal Article
Open access
PDF file
Jun LiJun Li
Jun Li
YYYuan Yuan
Yuan Yuan
CZChaofan Zhang
Chaofan Zhang
LMLanfei Miao
Lanfei Miao
JWJiaqiang Wu
Jiaqiang Wu
HAHongbin Ai
Hongbin Ai
Background: Little information is known about viral distribution and transmission of porcine circovirus type 2 (PCV2) in species other than swine. It is still a debated topic whether the PCV2 could be infected and caused clinical lesions. Our study is aimed to estimate the susceptibility of Kunming mouse to PCV2. Forty-eight, 6-week-old Kunming mice were randomly divided into four groups. Group A (C1-C12) was inoculated with PK-15 cell culture as a control group. Group B (sPCV1-12) was inoculated orally and intramuscularly with PCV2 (106.2TCID50/ml). Group C (mPCV1-12) was inoculated orally and intramuscularly with PCV2 (106.2TCID50/ml) and a booster inoculation at days 14 and 28 after the first inoculation. Group D (MixPCV1-12) was unvaccinated but released into Group C. Each group was sacrificed at 7, 14, 28, and 42 days post-inoculation, respectively. Necropsy was checked on every mouse. Sera samples were collected for the test of PCV2 specific antibody. Tissues were collected for histopathology study and polymerase chain reaction (PCR). Results: The results showed that viral replication, seroconversion, and microscopic lesions were found in inoculated mice. Continuous existence of PCV2 viruses in lymph nodes have been confirmed by PCR, which took at least seven days for the virus to be transferred into other organs from the primary interface, and the diffusion to thymus had been retarded for seven days. Special PCV2 antibody could be found in PCV2 inoculation mice and was significantly higher than that in the control. Further more, microscopic lesions and the main target of PCV2 focused in the lymph nodes with a characteristic depletion and occasional necrosis of lymphocytes in the cortex and paracortex were found in inoculated mice. Conclusions: The Kunming mouse could be infected by PCV2 virus and used as a PCV2 infected experimental model.

16 June 2025 in One Health
Verified
Journal Article
Open access
FLFei Liu
Fei Liu
SZShuzhi Zhang
Shuzhi Zhang
MEMihajlo Erdeljan
Mihajlo Erdeljan
YZYuyu Zhang
Yuyu Zhang
ZCZhi Chen
Zhi Chen
JWJiaqiang Wu
Jiaqiang Wu
The health of humans and the growth of the agriculture industry are seriously threatened by the emerging zoonotic pathogen Streptococcus suis (S. suis). In the last decades, evolutionary studies have significantly enhanced our understanding of S. suis. Currently, S. suis is widespread across numerous countries, in which it displays diverse serotypes and complex population structures. The widespread use of antibiotics across the globe has resulted in significant multi-drug resistance among clinical isolates of S. suis, creating a serious challenge in treating infections and presenting a considerable risk to public health and safety. This article briefly describes the transmission routes and infection symptoms of S. suis between different species, particularly in pigs and humans. The epidemiological situation and differences of S. suis in humans and pigs are further analyzed from three aspects of serotype, MLST, and WGS. Finally, the latest research progress on drug resistance mechanism of S. suis was reviewed. A deep understanding of the epidemiological situation and antimicrobial resistance characteristics of S. suis is crucial for crucial for mitigating the emergence of superbugs and for innovating new molecules or combinations of antimicrobials.